Vilacto Bio Inc. announced that it has retained The Equity Group Inc. to facilitate all aspects of the Company’s investor relations and financial communications. The company selected The Equity Group due to its 43-year track record of delivering specialized, comprehensive IR programs for small- and mid-sized public companies. The Equity Group combines legacy knowledge of capital markets communications, and an unparalleled reputation for integrity and client service with evolving industry best practices to design and execute investor relations programs that help deliver long-term shareholder value.